InsidersTradesSigma
와이바이오로직스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 와이바이오로직스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 와이바이오로직스 has published 24 insider filings. The latest transaction was disclosed on 9 July 2026 (Other). Among the most active insiders: 장명자. All data is accessible without an account.
24
Insider Decl.
0
Thresholds
€11,636
2 ops.
Buy Volume
·
2 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 July 2026
Declarations24 total
24 of 24 declarations
About 와이바이오로직스
와이바이오로직스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical products.